China National Medicines Corp Ltd Cash Flow Quality Index
China National Medicines Corp Ltd cash flow quality index. China National Medicines Corp Ltd (600511) has a Cash Flow Quality Index of -0.99x as of September 2025. Operating cash flow of CN¥-540.00 Million is below net income of CN¥543.72 Million, suggesting accrual-heavy earnings not yet converted to cash. See how financially flexible is China National Medicines Corp Ltd to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of China National Medicines Corp Ltd (2001–2024)
Cash flow quality index of China National Medicines Corp Ltd from 2001 to 2024. Historical Cash Flow Quality Index for China National Medicines Corp Ltd across 24 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore China National Medicines Corp Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
China National Medicines Corp Ltd Cash Flow Quality Index by Year (2001–2024)
China National Medicines Corp Ltd cash flow quality index by year from 2001 to 2024. Year-by-year earnings quality comparison for China National Medicines Corp Ltd. For the full cash flow conversion analysis, see China National Medicines Corp Ltd operating cash flow efficiency.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.78x | CN¥1.66 Billion | CN¥2.13 Billion | ▼ -33.3% |
| 2023 | 1.17x | CN¥2.73 Billion | CN¥2.33 Billion | ▲ +3.8% |
| 2022 | 1.13x | CN¥2.40 Billion | CN¥2.13 Billion | ▲ +10.9% |
| 2021 | 1.02x | CN¥1.96 Billion | CN¥1.93 Billion | ▲ +17.7% |
| 2020 | 0.86x | CN¥1.30 Billion | CN¥1.51 Billion | ▼ -8.7% |
| 2019 | 0.94x | CN¥1.78 Billion | CN¥1.88 Billion | ▲ +53.2% |
| 2018 | 0.62x | CN¥981.65 Million | CN¥1.59 Billion | ▼ -23.2% |
| 2017 | 0.80x | CN¥1.07 Billion | CN¥1.34 Billion | ▼ -23.5% |
| 2016 | 1.05x | CN¥591.25 Million | CN¥563.94 Million | ▲ +26.8% |
| 2015 | 0.83x | CN¥440.29 Million | CN¥532.31 Million | ▲ +88.2% |
| 2014 | 0.44x | CN¥218.94 Million | CN¥498.05 Million | ▲ +0.5% |
| 2013 | 0.44x | CN¥185.56 Million | CN¥424.11 Million | ▼ -19.0% |
| 2012 | 0.54x | CN¥185.87 Million | CN¥343.95 Million | ▲ +140.2% |
| 2011 | -1.34x | CN¥-370.56 Million | CN¥275.87 Million | ▼ -232.2% |
| 2010 | 1.02x | CN¥318.21 Million | CN¥313.26 Million | ▼ -8.7% |
| 2009 | 1.11x | CN¥255.18 Million | CN¥229.42 Million | ▲ +0.6% |
| 2008 | 1.11x | CN¥217.10 Million | CN¥196.38 Million | ▲ +81.1% |
| 2007 | 0.61x | CN¥79.48 Million | CN¥130.16 Million | ▼ -59.5% |
| 2006 | 1.51x | CN¥121.50 Million | CN¥80.62 Million | ▼ -28.9% |
| 2005 | 2.12x | CN¥92.20 Million | CN¥43.47 Million | ▲ +29.9% |
| 2004 | 1.63x | CN¥49.18 Million | CN¥30.13 Million | ▲ +10033.4% |
| 2003 | 0.02x | CN¥526.15K | CN¥32.66 Million | ▼ -97.3% |
| 2002 | 0.60x | CN¥15.19 Million | CN¥25.30 Million | ▲ +199.2% |
| 2001 | -0.61x | CN¥-11.80 Million | CN¥19.49 Million | — |